Most Recent
A settlement has been reached in three class action against the Commonwealth of Australia over the use of allegedly toxic firefighting foam at government military bases.
ASIC has criticised a Federal Court judge for his 'thought experiments' around prospective home loan applicants feasting on Wagyu beef and shiraz, as the regulator challenges the judge's dismissal of its responsible lending case against Westpac.
The ACCC claims it was not required to prove Kimberly-Clark's flushable wipes caused actual harm to sewers, as it challenges a ruling that disposed of its consumer law case against the personal care giant.
Dam operator Seqwater will appeal its loss in a long-running class action over the 2011 Queensland floods that destroyed over 2,000 homes, a move derided by the lawyer for the flood victims, who called for "an end to the injustice" her clients have suffered.
Baker McKenzie has nabbed former King & Wood Mallesons special counsel Charlie Detmold for the law firm's key banking and finance practice in Melbourne.
An ACCC officer who was heading up a team investigating alleged cartel conduct by ANZ Banking Group and three investment banks has admitted that the regulator may have made an 'oversight' in a letter of comfort offered to JPMorgan ahead of the bank's immunity application in the case.
During another day of cross-examination in a criminal cartel case against ANZ and two investment banks, a key ACCC officer was accused of lying about his interrogation of a key cartel witness, with the officer insisting there was nothing "sinister" in his examination.
An ACCC investigator has come under fire from ANZ as the bank seeks to shoot holes in the criminal cartel action against it, with counsel for the bank accusing the regulator of "infecting" witness statements and erasing testimony that weakened its case.
A key officer from the ACCC involved in interviewing JPMorgan bankers during a cartel investigation that led to criminal charges against ANZ and two investment banks has denied allegations that he acted improperly during the investigation.
Two biotech companies that provide molecular diagnostic products used in genetic screening will face off in Federal Court over whether one of the company's 'Access' trade mark is likely to confuse consumers.